Citation:O'Rourke N, Roqué I Figuls M, Farré Bernadó N, Macbeth F 2010

From Cancer Guidelines Wiki

Citation


O'Rourke N, Roqué I Figuls M, Farré Bernadó N, Macbeth F. Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev 2010 Jun 16;(6):CD002140 Available from: http://www.ncbi.nlm.nih.gov/pubmed/20556756.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
O'Rourke N, Roqué I Figuls M, Farré Bernadó N, Macbeth F 2010What is the recommended treatment approach for the definitive management of patients with good performance status and inoperable stage III disease?Dr Margot Lehman MBBS FRANZCR GDPcompleted
O'Rourke N, Roqué I Figuls M, Farré Bernadó N, Macbeth F 2010 2What is the optimal management of Pancoast tumours?Dr Margot Lehman MBBS FRANZCR GDPcompleted
O'Rourke N, Roqué I Figuls M, Farré Bernadó N, Macbeth F 2010 3What is the role of chemotherapy when added to radiotherapy in the treatment of inoperable stage II NSCLC?Dr Shawgi Sukumarancompleted
O'Rourke N, Roqué I Figuls M, Farré Bernadó N, Macbeth F 2010 4What is the optimal chemotherapy regime in concurrent chemo-radiotherapy in inoperable stage III NSCLC?Dr Adelaide Morgancompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the recommended treatment approach for the definitive management of patients with good performance status and inoperable stage III disease?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the recommended treatment approach for the definitive management of patients with good performance status and inoperable stage III disease?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the optimal management of Pancoast tumours?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the optimal management of Pancoast tumours?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the role of chemotherapy when added to radiotherapy in the treatment of inoperable stage II NSCLC?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the role of chemotherapy when added to radiotherapy in the treatment of inoperable stage II NSCLC?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the optimal chemotherapy regime in concurrent chemo-radiotherapy in inoperable stage III NSCLC?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the optimal chemotherapy regime in concurrent chemo-radiotherapy in inoperable stage III NSCLC?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What is the optimal management of Pancoast tumours?
  2. What is the recommended treatment approach for the definitive management of patients with good performance status and inoperable stage III disease?
  3. What is the role of chemotherapy when added to radiotherapy in the treatment of inoperable stage II NSCLC?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:O%27Rourke_N,_Roqué_I_Figuls_M,_Farré_Bernadó_N,_Macbeth_F_2010&oldid=20745"